Form 8-K Tarsus Pharmaceuticals, For: Jul 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/19/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Medifast launches Trilivy, replacing its Optavia brand
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
Tarsus Pharmaceuticals CCO to depart for medical device CEO role
July 13, 2026 4:14 PM EDTTarsus Pharmaceuticals (NASDAQ: TARS) announced that Aziz Mottiwala will leave his position as Chief Commercial Officer on July 15, 2026, to become Chief Executive Officer of a public medical device company.
... More